查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564071

全球细胞扩增市场

Cell Expansion
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球电池扩产市场预计将达到869亿美元

预计2023年全球电池扩产市场规模为331亿美元，预计到2030年将达869亿美元，2023年至2030年复合年增长率为14.8%。细胞扩增耗材是本报告分析的细分市场之一，复合年增长率为16.0%，预计到分析期末将达到424亿美元。在分析期间，蜂窝扩展设备领域的复合年增长率预计为 12.5%。

美国市场预计91亿美元，中国预计复合年增长率13.9%

预计到 2023 年，美国电池市场的规模将扩大至 91 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达131亿美元，2023-2030年分析期间复合年增长率为13.9%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 13.1% 和 12.3%。在欧洲，德国预计复合年增长率为 10.6%。

不断扩大的全球电池市场 - 主要趋势和驱动因素总结

细胞扩增将如何彻底改变治疗和研究？

细胞扩增是生物医学研究和先进治疗方法开发的关键过程，允许从有限的起始群体中产生大量细胞。这项技术是再生医学、肿瘤学和免疫治疗等领域的基础，这些领域的研究、药物发现和治疗需要大量的功能性细胞。在干细胞治疗的背景下，细胞扩增能够产生足够的干细胞用于组织再生和退化性疾病的治疗。在癌症研究中，T细胞等免疫细胞的增殖能力为CAR T细胞疗法等免疫疗法铺平了道路。透过提供一种有效的方法来增加细胞数量，同时保持细胞活力和功能，细胞扩增正在推动临床和研究领域的创新。反应器技术和培养基的进步使细胞生长过程更加可扩展和精确，使科学家和临床医生能够生产用于各种治疗应用的高品质细胞。

为什么细胞扩增对于再生医学和免疫疗法至关重要？

细胞扩增对于再生医学和免疫疗法的进步至关重要，这两个领域是现代医疗保健中最有前景的领域。再生医学严重依赖干细胞，干细胞具有分化成各种类型细胞并修復受损组织的能力。为了开发针对脊髓损伤、心臟病和糖尿病等疾病的有效治疗方法，研究人员必须培养大量干细胞。面临的挑战是维持干细胞的多功能并维持其分化为所需细胞的能力。另一方面，免疫疗法依赖 T 细胞等免疫细胞的增殖。例如，CAR-T细胞疗法的成功取决于将T细胞扩增至足够数量以实现治疗效果的能力。随着此类治疗方法的采用不断增加，对强大的细胞扩增系统的需求日益增长，该系统可以支持大规模生产而不影响细胞安全性和功效。随着对细胞疗法的需求不断增加，细胞扩增技术变得越来越复杂，以应对临床应用中可扩展性和法规遵循的挑战。

科技进步如何彻底改变细胞扩增？

技术进步彻底改变了细胞​​扩增的过程，使其更有效率、可扩展并适应现代科学的需求。最重要的技术创新之一是反应器的开发。反应器为细胞生长提供受控环境，使细胞能够大规模扩增，同时保持最佳的活力和功能条件。这些反应器配备了自动化系统，可监测和调整温度、氧气和营养水平等关键参数，确保结果的一致性和可重复性。此外，培养基的创新使得优化特定细胞类型的营养需求成为可能，进一步提高扩增细胞的品质和产量。微载体为细胞在悬浮液中生长提供了表面，扩大了反应器的容量，使它们能够更有效地产生更高的细胞密度。自动化和人工智慧 (AI) 的进步也发挥着关键作用，使细胞培养环境中的即时监控和决策成为可能。这些技术正在帮助研究人员和临床医生减少生产治疗细胞的时间和成本，同时提高扩充性并简化临床和工业应用的流程。

推动细胞扩增市场成长的因素有哪些？

细胞扩增市场的成长是由多种因素所推动的，例如对细胞疗法的需求增加、生物加工技术的进步以及慢性病盛行率的增加。随着越来越多的细胞疗法（例如 CAR-T 细胞疗法和干细胞疗法）进入临床，对可靠且可扩展的细胞扩增方法的需求正在迅速增加。技术创新，特别是反应器和自动化，使得生产大量细胞变得更加容易，同时保持品质和治疗潜力。细胞扩增在再生医学（利用干细胞修復或替换受损组织）中的日益使用也是一个重要的驱动因素，因为它需要高效且可扩展的系统来生产这些治疗所需的大量细胞。此外，癌症、糖尿病和心血管疾病的盛行率日益增加，正在刺激依赖扩增细胞的新治疗方法的研究，例如免疫疗法和再生疗法。此外，细胞治疗方法核准的监管进展正在鼓励对生物製程基础设施的投资，进一步推动市场成长。随着消费者对个人化医疗意识的增强，对客製化细胞疗法的需求预计将加速，为创新细胞扩增技术的发展创造新的机会。总的来说，这些因素推动了细胞扩增市场的快速扩张，使其成为生物技术和医疗保健的关键成长领域。

受访企业范例（共12家）

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10941

Global Cell Expansion Market to Reach US$86.9 Billion by 2030

The global market for Cell Expansion estimated at US$33.1 Billion in the year 2023, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the analysis period. Growth in the Cell Expansion Instruments segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 13.9% CAGR

The Cell Expansion market in the U.S. is estimated at US$9.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.1% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Cell Expansion Market - Key Trends and Drivers Summarized

How Is Cell Expansion Transforming Therapeutics and Research?

Cell expansion is a pivotal process in biomedical research and the development of advanced therapies, enabling the production of large quantities of cells from a limited starting population. This technique is fundamental in fields such as regenerative medicine, oncology, and immunotherapy, where vast numbers of functional cells are required for research, drug discovery, or therapeutic use. In the context of stem cell therapy, cell expansion allows for the generation of enough stem cells to support tissue regeneration or to treat degenerative diseases. In cancer research, the ability to expand immune cells, such as T cells, has paved the way for immunotherapies like CAR-T cell treatments, which require billions of engineered immune cells to effectively target and destroy cancerous cells. By providing an efficient means of increasing cell numbers while maintaining their viability and functionality, cell expansion is driving innovation in both clinical and research environments. With advancements in bioreactor technology and culture media, the process of expanding cells has become more scalable and precise, ensuring that scientists and clinicians can produce high-quality cells for a variety of therapeutic applications.

Why Is Cell Expansion Critical for Regenerative Medicine and Immunotherapy?

Cell expansion is indispensable for the advancement of regenerative medicine and immunotherapy, two of the most promising fields in modern healthcare. Regenerative medicine relies heavily on stem cells, which have the ability to differentiate into various cell types and repair damaged tissues. To create effective treatments for conditions such as spinal cord injuries, heart disease, or diabetes, researchers must expand stem cells in large quantities. The challenge lies in maintaining the pluripotency of these cells during the expansion process, ensuring that they retain their capacity to transform into the needed cell types. Immunotherapy, on the other hand, depends on the expansion of immune cells like T cells, which are modified and multiplied to fight diseases such as cancer. The success of CAR-T cell therapy, for instance, hinges on the ability to expand these engineered T cells to sufficient numbers to achieve therapeutic efficacy. The growing adoption of these therapies has increased the need for robust cell expansion systems that can support large-scale production without compromising the safety and potency of the cells. As the demand for cell-based therapies continues to rise, cell expansion technologies are becoming more sophisticated to meet the challenges of scalability and regulatory compliance in clinical applications.

How Are Technological Advancements Revolutionizing Cell Expansion?

Technological advancements are revolutionizing the process of cell expansion, making it more efficient, scalable, and adaptable to the needs of modern science. One of the most significant innovations is the development of bioreactors, which provide controlled environments for cell growth, enabling the expansion of cells on a large scale while maintaining optimal conditions for viability and function. These bioreactors are equipped with automated systems that monitor and adjust critical parameters such as temperature, oxygen, and nutrient levels, ensuring consistent and reproducible results. Additionally, innovations in culture media have made it possible to optimize the nutritional needs of specific cell types, further improving the quality and yield of expanded cells. Microcarriers, which offer a surface for cells to grow in suspension, have expanded the capacity of bioreactors, making them more efficient in producing high cell densities. Advances in automation and artificial intelligence (AI) are also playing a crucial role, enabling real-time monitoring and decision-making in cell culture environments. These technologies help researchers and clinicians streamline the cell expansion process, reducing the time and cost associated with producing therapeutic cells while increasing scalability for clinical and industrial use.

What Factors Are Driving Growth in the Cell Expansion Market?

The growth in the cell expansion market is driven by several factors, including the increasing demand for cell-based therapies, advancements in bioprocessing technologies, and the growing prevalence of chronic diseases. As more cell-based therapies, such as CAR-T cell treatments and stem cell therapies, enter clinical practice, the need for reliable and scalable cell expansion methods is rising rapidly. Technological innovations, particularly in bioreactors and automation, have made it easier to produce large quantities of cells while maintaining their quality and therapeutic potential. The expanding use of cell expansion in regenerative medicine, where stem cells are employed to repair or replace damaged tissues, is another significant driver, as it requires efficient and scalable systems to produce the high volumes of cells necessary for these treatments. Moreover, the growing incidence of cancer, diabetes, and cardiovascular diseases is fueling research into new therapies that depend on expanded cells, such as immunotherapies and regenerative treatments. Additionally, regulatory advancements in the approval of cell-based therapies are encouraging investments in bioprocessing infrastructure, further propelling market growth. As consumer awareness of personalized medicine increases, the demand for customized cell therapies is expected to accelerate, creating new opportunities for the development of innovative cell expansion technologies. These factors are collectively driving the rapid expansion of the cell expansion market, positioning it as a key area of growth in biotechnology and healthcare.

Select Competitors (Total 12 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Expansion - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cell-Based Therapies Expands Market for Cell Expansion Technologies
    • Advancements in Bioreactor Technology Propel Growth in Scalable Cell Expansion
    • Increasing Focus on Personalized Medicine Strengthens Business Case for Cell Expansion
    • Stem Cell Research and Regenerative Medicine Fuel Market for Optimized Cell Expansion
    • Technological Innovations in 3D Cell Culture Expand Opportunities in Cell Expansion
    • Automation in Cell Expansion Systems Spurs Market Growth in High-Throughput Applications
    • Adoption of CAR-T Cell Therapy Boosts Need for Large-Scale Cell Expansion Solutions
    • Rising Prevalence of Chronic Diseases Accelerates Demand for Advanced Cell Expansion Techniques
    • Emergence of Allogeneic Therapies Creates New Opportunities for Scalable Cell Expansion
    • Shift Toward Automation and AI-Driven Systems Creates New Possibilities in Cell Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Expansion Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION